Subscribe to RSS
DOI: 10.1055/s-0043-1777749
Electrophysiological evaluation of the neuromuscular junction: a brief review
Avaliação eletrofisiológica da junção neuromuscular: breve revisão Support João Aris Kouyoumdjian was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Brazil. Grant numbers: 2008-10082-6, 2017/13262-4, and 2022/02291-1, all related to single-fiber electromyography.Abstract
The nerve terminal and muscle membrane compose the neuromuscular junction. After opening the voltage-gated calcium channels, action potentials from the motor axons provoke a cascade for the acetylcholine release from synaptic vesicles to the synaptic cleft, where it binds to its receptor at the muscle membrane for depolarization. Low amplitude compound muscle action potential typically presents in presynaptic disorders, increasing by more than 100% after a 10-second effort in the Lambert-Eaton myasthenic syndrome and less in botulism. Needle electromyography may show myopathic motor unit action potentials and morphological instability (“jiggle”) due to impulse blocking. Low-frequency repetitive nerve stimulation (RNS) is helpful in postsynaptic disorders, such as myasthenia gravis and most congenital myasthenic syndromes, where the number of functioning acetylcholine receptors is reduced. Low-frequency RNS with a decrement >10% is abnormal when comparing the 4th to the first compound muscle action potential amplitude. High-frequency RNS is helpful in presynaptic disorders like Lambert-Eaton myasthenic syndrome, botulism, and some rare congenital myasthenic syndromes. The high-frequency RNS releases more calcium, increasing the acetylcholine with a compound muscle action potential increment. Concentric needle records apparent single-fiber action potentials (spikes). A voluntary activation measures the jitter between spikes from two endplates. An electrical activation measures the jitter of one spike (one endplate). The jitter is the most sensitive test for detecting a neuromuscular junction dysfunction. Most neuromuscular junction disorders are responsive to treatment.
Resumo
O nervo terminal e a membrana muscular compõem a junção neuromuscular. Após a abertura dos canais de cálcio dependentes de voltagem, os potenciais de ação do axônio motor provocam uma cascata de eventos que libera acetilcolina das vesículas para a fenda sináptica, ligando-se ao receptor na membrana muscular para despolarização. O potencial de ação muscular composto de baixa amplitude ocorre nas desordens pré-sinápticas, aumentando em mais de 100% após esforço de 10 segundos na síndrome miastênica de Lambert-Eaton e menos no botulismo. A eletromiografia pode mostrar potenciais de ação da unidade motora miopáticos e instabilidade morfológica (“jiggle”) devido ao bloqueio do impulso. Estimulação nervosa repetitiva (ENR) de baixa frequência é útil nos distúrbios pós-sinápticos, como miastenia gravis e a maioria das síndromes miastênicas congênitas, quando há número reduzido de receptores de acetilcolina funcionantes. ENR de baixa frequência com decremento >10% é anormal comparando-se à amplitude do quarto com o primeiro potencial de ação muscular composto. ENR de alta frequência é útil nas doenças pré-sinápticas, como síndrome miastênica de Lambert-Eaton, botulismo e algumas síndromes miastênicas congênitas raras. ENR de alta frequência libera mais cálcio, aumenta acetilcolina, resultando em incremento do potencial de ação muscular composto. O eletrodo de agulha concêntrico registra potenciais de ação aparente de fibra única (PAAFU). Ativação voluntária mede jitter entre dois PAAFUs (duas junções neuromusculares). Ativação elétrica mede jitter de um PAAFU (uma junção neuromuscular). Jitter é o teste mais sensível para detectar disfunção de junção neuromuscular. A maioria dos distúrbios juncionais é responsiva ao tratamento.
Keywords
Neuromuscular Junction - Myasthenia Gravis - Repetitive Nerve Stimulation - Single-Fiber Electromyography - JitterPalavras-chave
Junção Neuromuscular - Miastenia Gravis - Estimulação Nervosa Repetitiva - Eletromiografia de Fibra Única - JitterAuthors' Contributions
JK: design the project (conceptualization) after an invitation from the Arquivos de Neuro-Psiquiatria editorial board to publish a review of the electrophysiologic evaluation of the neuromuscular junction. Data curation, formal analysis and methodology, do not apply for review article; ES: wrote the congenital myasthenic syndrome section. Both authors revised the articles, the final version of the manuscript, figures, and tables. (Soffware used: Microsoft Word® and Microsoft Power-Point®.)
Publication History
Received: 17 August 2023
Accepted: 17 November 2023
Article published online:
29 December 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Kuffler SW, Yoshikami D. The number of transmitter molecules in a quantum: an estimate from iontophoretic application of acetylcholine at the neuromuscular synapse. J Physiol 1975; 251 (02) 465-482 DOI: 10.1113/jphysiol.1975.sp011103.
- 2 Fatt P, Katz B. An analysis of the end-plate potential recorded with an intracellular electrode. J Physiol 1951; 115 (03) 320-370 DOI: 10.1113/jphysiol.1951.sp004675.
- 3 Ruff RL. Endplate contributions to the safety factor for neuromuscular transmission. Muscle Nerve 2011; 44 (06) 854-861 DOI: 10.1002/mus.22177.
- 4 Kaminski HJ, Suarez JI, Ruff RL. Neuromuscular junction physiology in myasthenia gravis Isoforms of the acetylcholine receptor in extraocular muscle and the contribution of sodium channels to the safety factor. Neurology 1997; 48 (Suppl 5): 8S-17S DOI: 10.1212/WNL.48.Suppl_5.8S.
- 5 Albuquerque EX, Barnard EA, Porter CW, Warnick JE. The density of acetylcholine receptors and their sensitivity in the postsynaptic membrane of muscle endplates. Proc Natl Acad Sci U S A 1974; 71 (07) 2818-2822 DOI: 10.1073/pnas.71.7.2818.
- 6 Slater CR. Chapter 2: Reliability of neuromuscular transmission and how it is maintained. In: Handbook of Clinical Neurology, Vol. 91 (3rd series), Neuromuscular junction disorders, Engel AG (Ed), Ch 2, pp 27–101, Elsevier BV, 2008
- 7 Wood SJ, Slater CR. Safety factor at the neuromuscular junction. Prog Neurobiol 2001; 64 (04) 393-429 DOI: 10.1016/s0301-0082(00)00055-1.
- 8 Mongiovi PC, Elsheikh B, Lawson VH, Kissel JT, Arnold WD. Neuromuscular junction disorders mimicking myopathy. Muscle Nerve 2014; 50 (05) 854-856 DOI: 10.1002/mus.24300.
- 9 AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine. Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement. Muscle Nerve 2001; 24 (09) 1236-1238 DOI: 10.1002/mus.1139.
- 10 Oh SJ, Eslami N, Nishihira T. et al. Electrophysiological and clinical correlation in myasthenia gravis. Ann Neurol 1982; 12 (04) 348-354 DOI: 10.1002/ana.410120406.
- 11 Howard Jr JF. Electrodiagnosis of disorders of neuromuscular transmission. Phys Med Rehabil Clin N Am 2013; 24 (01) 169-192 DOI: 10.1016/j.pmr.2012.08.013.
- 12 Rubin DI, Hentschel K. Is exercise necessary with repetitive nerve stimulation in evaluating patients with suspected myasthenia gravis?. Muscle Nerve 2007; 35 (01) 103-106 DOI: 10.1002/mus.20667.
- 13 Camelo-Filho AE, Estephan EP, Heise CO, Zanoteli E. Teaching Video NeuroImage: Reflex Facilitation in Lambert-Eaton Myasthenic Syndrome. Neurology 2021; 97 (11) e1168-e1169 DOI: 10.1212/WNL.0000000000012180.
- 14 Sanders DB, Cao L, Massey JM, Juel VC, Hobson-Webb L, Guptill JT. Is the decremental pattern in Lambert-Eaton syndrome different from that in myasthenia gravis?. Clin Neurophysiol 2014; 125 (06) 1274-1277 DOI: 10.1016/j.clinph.2013.11.007.
- 15 Elahi B, Laughlin RS, Litchy WJ, Milone M, Liewluck T. Neuromuscular transmission defects in myopathies: Rare but worth searching for. Muscle Nerve 2019; 59 (04) 475-478 DOI: 10.1002/mus.26393.
- 16 Friedman-Korn T, Lerner Y, Haggiag S. et al. Pearls & Oy-sters: Reversible Postpartum Pseudocoma State Associated With Magnesium Therapy: A Report of 2 Cases. Neurology 2022; 99 (10) 433-436 DOI: 10.1212/WNL.0000000000200956.
- 17 Sanders DB, Kouyoumdjian JA, Stålberg EV. Single fiber EMG and measuring jitter with concentric needle electrodes. Muscle Nerve 2022; 66 (02) 118-130 DOI: 10.1002/mus.27572.
- 18 Stålberg EV, Trontelj JV, Sanders DB. Single fiber EMG, 3rd ed. Fiskebäckskil, Sweden:: Edshagen Publishing House;; 2010
- 19 Gilchrist JM. Ad Hoc Committee of the AAEM Special Interest Group on Single Fiber EMG. Single fiber EMG reference values: a collaborative effort. Muscle Nerve 1992; 15 (02) 151-161 DOI: 10.1002/mus.880150205.
- 20 Ertaş M, Baslo MB, Yildiz N, Yazici J, Oge AE. Concentric needle electrode for neuromuscular jitter analysis. Muscle Nerve 2000; 23 (05) 715-719 DOI: 10.1002/(sici)1097-4598(200005)23:5<715:aid-mus8>3.0.co;2-v.
- 21 Stålberg EV, Sanders DB. Jitter recordings with concentric needle electrodes. Muscle Nerve 2009; 40 (03) 331-339 DOI: 10.1002/mus.21424.
- 22 Stålberg E, Sanders DB, Ali S. et al. Reference values for jitter recorded by concentric needle electrodes in healthy controls: A multicenter study. Muscle Nerve 2016; 53 (03) 351-362 DOI: 10.1002/mus.24750.
- 23 Kouyoumdjian JA, Stålberg EV. Concentric needle single fiber electromyography: normative jitter values on voluntary activated Extensor Digitorum Communis. Arq Neuropsiquiatr 2007; 65 (2B): 446-449 . Doi: 10.1590/s0004-282. Doi: × 2007000300016
- 24 Kouyoumdjian JA, Stålberg EV. Reference jitter values for concentric needle electrodes in voluntarily activated extensor digitorum communis and orbicularis oculi muscles. Muscle Nerve 2008; 37 (06) 694-699 DOI: 10.1002/mus.21043.
- 25 Kouyoumdjian JA, Stålberg EV. Concentric needle single fiber electromyography: comparative jitter on voluntary-activated and stimulated Extensor Digitorum Communis. Clin Neurophysiol 2008; 119 (07) 1614-1618 DOI: 10.1016/j.clinph.2008.03.008.
- 26 Kouyoumdjian JA, Stålberg EV. Concentric needle jitter on stimulated Orbicularis Oculi in 50 healthy subjects. Clin Neurophysiol 2011; 122 (03) 617-622 DOI: 10.1016/j.clinph.2010.07.012.
- 27 Kouyoumdjian JA, Stålberg EV. Concentric needle jitter in stimulated frontalis in 20 healthy subjects. Muscle Nerve 2012; 45 (02) 276-278 DOI: 10.1002/mus.22306.
- 28 Kouyoumdjian JA, Stålberg EV. Concentric needle jitter on voluntary activated frontalis in 20 healthy subjects. Muscle Nerve 2013; 47 (03) 440-442 DOI: 10.1002/mus.23710.
- 29 Kokubun N, Sonoo M, Imai T. et al; Japanese SFEMG Study Group. Reference values for voluntary and stimulated single-fibre EMG using concentric needle electrodes: a multicentre prospective study. Clin Neurophysiol 2012; 123 (03) 613-620 DOI: 10.1016/j.clinph.2011.07.044.
- 30 Valls-Canals J, Montero J, Pradas J. Stimulated single fiber EMG of the frontalis muscle in the diagnosis of ocular myasthenia. Muscle Nerve 2000; 23 (05) 779-783 DOI: 10.1002/(sici)1097-4598(200005)23:5<779:aid-mus16>3.0.co;2-z.
- 31 Valls-Canals J, Povedano M, Montero J, Pradas J. Stimulated single-fiber EMG of the frontalis and orbicularis oculi muscles in ocular myasthenia gravis. Muscle Nerve 2003; 28 (04) 501-503 DOI: 10.1002/mus.10426.
- 32 Trontelj JV, Mihelin M, Fernandez JM, Stålberg E. Axonal stimulation for end-plate jitter studies. J Neurol Neurosurg Psychiatry 1986; 49 (06) 677-685 DOI: 10.1136/jnnp.49.6.677.
- 33 Trontelj JV, Khuraibet A, Mihelin M. The jitter in stimulated orbicularis oculi muscle: technique and normal values. J Neurol Neurosurg Psychiatry 1988; 51 (06) 814-819 DOI: 10.1136/jnnp.51.6.814.
- 34 Stålberg E, Sanders DB, Kouyoumdjian JA. Pitfalls and errors in measuring jitter. Clin Neurophysiol 2017; 128 (11) 2233-2241 DOI: 10.1016/j.clinph.2017.09.001.
- 35 Sanders DB, Arimura K, Cui L. et al. Guidelines for single fiber EMG. Clin Neurophysiol 2019; 130 (08) 1417-1439 DOI: 10.1016/j.clinph.2019.04.005.
- 36 Massey JM, Sanders DB, Howard Jr JF. The effect of cholinesterase inhibitors of SFEMG in myasthenia gravis. Muscle Nerve 1989; 12 (02) 154-155 DOI: 10.1002/mus.880120211.
- 37 Kouyoumdjian JA, Ronchi LG, de Faria FO. Jitter evaluation in denervation and reinnervation in 32 cases of chronic radiculopathy. Clin Neurophysiol Pract 2020; 5: 165-172 DOI: 10.1016/j.cnp.2020.07.006.
- 38 Kouyoumdjian JA, Graça CR, Oliveira FN. Jitter Evaluation in Distant and Adjacent Muscles after Botulinum Neurotoxin Type A Injection in 78 Cases. Toxins (Basel) 2020; 12 (09) 549 DOI: 10.3390/toxins12090549.
- 39 Ozkul Y. Influence of calcium channel blocker drugs in neuromuscular transmission. Clin Neurophysiol 2007; 118 (09) 2005-2008 DOI: 10.1016/j.clinph.2007.06.002.
- 40 Silva A, Maduwage K, Buckley NA, Lalloo DG, de Silva HJ, Isbister GK. Antivenom for snake venom-induced neuromuscular paralysis. Cochrane Database Syst Rev 2017; (03) CD012604 DOI: 10.1002/14651858.CD012604.
- 41 Rivner MH, Quarles BM, Pan JX. et al. Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study. Muscle Nerve 2020; 62 (03) 333-343 DOI: 10.1002/mus.26985.
- 42 Evoli A, Tonali PA, Padua L. et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003; 126 (Pt 10): 2304-2311 DOI: 10.1093/brain/awg223.
- 43 Padua L, Tonali P, Aprile I, Caliandro P, Bartoccioni E, Evoli A. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients. Eur J Neurol 2006; 13 (03) 273-276 DOI: 10.1111/j.1468-1331.2006.01214.x.
- 44 Chiou-Tan FY, Gilchrist JM. Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: Review of recent literature. Muscle Nerve 2015; 52 (03) 455-462 DOI: 10.1002/mus.24745.
- 45 Srivastava A, Kalita J, Misra UK. A comparative study of single fiber electromyography and repetitive nerve stimulation in consecutive patients with myasthenia gravis. Electromyogr Clin Neurophysiol 2007; 47 (02) 93-96
- 46 Kouyoumdjian JA, Paiva GP, Stålberg E. Concentric Needle Jitter in 97 Myasthenia Gravis Patients. Front Neurol 2020; 11: 600680 DOI: 10.3389/fneur.2020.600680.
- 47 Weinberg DH, Rizzo III JF, Hayes MT, Kneeland MD, Kelly Jr JJ. Ocular myasthenia gravis: predictive value of single-fiber electromyography. Muscle Nerve 1999; 22 (09) 1222-1227 DOI: 10.1002/(sici)1097-4598(199909)22:9<1222:aid-mus8>3.0.co;2-r.
- 48 Padua L, Stålberg E, LoMonaco M, Evoli A, Batocchi A, Tonali P. SFEMG in ocular myasthenia gravis diagnosis. Clin Neurophysiol 2000; 111 (07) 1203-1207 DOI: 10.1016/s1388-2457(00)00307-2.
- 49 Lo YL, Leoh TH, Tan YE, Foo ML, Dan YF, Ratnagopal P. Repetitive hypoglossal nerve stimulation in myasthenia gravis. Clin Neurophysiol 2002; 113 (08) 1227-1230 DOI: 10.1016/s1388-2457(02)00120-7.
- 50 Meriggioli MN, Rowin J. Single fiber EMG as an outcome measure in myasthenia gravis: results from a double-blind, placebo-controlled trial. J Clin Neurophysiol 2003; 20 (05) 382-385 DOI: 10.1097/00004691-200309000-00011.
- 51 Witoonpanich R, Dejthevaporn C, Sriphrapradang A, Pulkes T. Electrophysiological and immunological study in myasthenia gravis: diagnostic sensitivity and correlation. Clin Neurophysiol 2011; 122 (09) 1873-1877 DOI: 10.1016/j.clinph.2011.02.026.
- 52 Farrugia ME, Kennett RP, Newsom-Davis J, Hilton-Jones D, Vincent A. Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis. Muscle Nerve 2006; 33 (04) 568-570 DOI: 10.1002/mus.20491.
- 53 Oh SJ, Hatanaka Y, Hemmi S. et al. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis. Muscle Nerve 2006; 33 (04) 500-504 DOI: 10.1002/mus.20498.
- 54 Stickler DE, Massey JM, Sanders DB. MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns. Clin Neurophysiol 2005; 116 (09) 2065-2068 DOI: 10.1016/j.clinph.2005.06.003.
- 55 Guptill JT, Sanders DB, Evoli A. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve 2011; 44 (01) 36-40 DOI: 10.1002/mus.22006.
- 56 Abraham A, Alabdali M, Alsulaiman A. et al. Repetitive nerve stimulation cutoff values for the diagnosis of myasthenia gravis. Muscle Nerve 2017; 55 (02) 166-170 DOI: 10.1002/mus.25214.
- 57 Tomschik M, Renaud E, Jäger F. et al. The diagnostic and prognostic utility of repetitive nerve stimulation in patients with myasthenia gravis. Sci Rep 2023; 13 (01) 2985 DOI: 10.1038/s41598-023-30154-5.
- 58 Tim RW, Massey JM, Sanders DB. Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment. Neurology 2000; 54 (11) 2176-2178 DOI: 10.1212/wnl.54.11.2176.
- 59 Oh SJ, Kurokawa K, Claussen GC, Ryan Jr HF. Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome. Muscle Nerve 2005; 32 (04) 515-520 DOI: 10.1002/mus.20389.
- 60 Stålberg EV, Sonoo M. Assessment of variability in the shape of the motor unit action potential, the “jiggle,” at consecutive discharges. Muscle Nerve 1994; 17 (10) 1135-1144 DOI: 10.1002/mus.880171003.
- 61 Trontelj JV, Stålberg E. Single motor end-plates in myasthenia gravis and LEMS at different firing rates. Muscle Nerve 1991; 14 (03) 226-232 DOI: 10.1002/mus.880140305.
- 62 Chaudhry V, Watson DF, Bird SJ, Cornblath DR. Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome. Muscle Nerve 1991; 14 (12) 1227-1230 DOI: 10.1002/mus.880141215.
- 63 Sanders DB. The effect of firing rate on neuromuscular jitter in Lambert-Eaton myasthenic syndrome. Muscle Nerve 1992; 15 (02) 256-258
- 64 Raja SM. Lambert-Eaton Myasthenic Syndrome and Botulism. Continuum (Minneap Minn) 2022; 28 (06) 1596-1614 DOI: 10.1212/CON.0000000000001205.
- 65 Girlanda P, Dattola R, Messina C. Single fibre EMG in 6 cases of botulism. Acta Neurol Scand 1983; 67 (02) 118-123 DOI: 10.1111/j.1600-0404.1983.tb04553.x.
- 66 Padua L, Aprile I, Monaco ML. et al. Neurophysiological assessment in the diagnosis of botulism: usefulness of single-fiber EMG. Muscle Nerve 1999; 22 (10) 1388-1392 DOI: 10.1002/(sici)1097-4598(199910)22:10<1388:aid-mus8>3.0.co;2-3.
- 67 Estephan EP, Zambon AA, Thompson R. et al. Congenital myasthenic syndrome: Correlation between clinical features and molecular diagnosis. Eur J Neurol 2022; 29 (03) 833-842 DOI: 10.1111/ene.15173.
- 68 Ohno K, Ohkawara B, Shen XM, Selcen D, Engel AG. Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review. Int J Mol Sci 2023; 24 (04) 3730 DOI: 10.3390/ijms24043730.
- 69 Mihaylova V, Scola RH, Gervini B. et al. Molecular characterisation of congenital myasthenic syndromes in Southern Brazil. J Neurol Neurosurg Psychiatry 2010; 81 (09) 973-977 DOI: 10.1136/jnnp.2009.177816.
- 70 Estephan EP, Sobreira CFDR, Dos Santos ACJ. et al. A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome. J Neurol 2018; 265 (03) 708-713 DOI: 10.1007/s00415-018-8736-8.
- 71 Estephan EP, Zambon AA, Marchiori PE. et al. Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in Brazil. Neuromuscul Disord 2018; 28 (11) 961-964 DOI: 10.1016/j.nmd.2018.08.007.
- 72 Caldas VM, Heise CO, Kouyoumdjian JA. et al. Electrophysiological study of neuromuscular junction in congenital myasthenic syndromes, congenital myopathies, and chronic progressive external ophthalmoplegia. Neuromuscul Disord 2020; 30 (11) 897-903 DOI: 10.1016/j.nmd.2020.10.002.